ALZAMEND NEURO INC
ALZN·02262M308·US·Common Stock·Healthcare - Biotechnology
ALZN (ALZAMEND NEURO INC) is held by 5 institutional investors as of Q2 2026. Largest holders: GEODE CAPITAL MANAGEMENT, LLC ($31,644), VANGUARD FIDUCIARY TRUST CO ($25,224), VANGUARD CAPITAL MANAGEMENT LLC ($9,067). Net institutional sentiment: Bearish.
5
Holders
$69,281
Total Value
20% (5)
Consensus
1 buying - 4 selling
13F: Insider & Congress: Updated regularly
Who's Trading
Source dates: Price Oct 13, 2026 · Insiders Aug 31, 2026 · Activists none · Congress none
InsiderAIAULT MILTON C IIISell $3KAug 26, 2026
InsiderAIAULT MILTON C IIIBuy $2KApr 14, 2026
InsiderAIAULT MILTON C IIIBuy $109KApr 14, 2026
Checking access…
Top Holders
Checking access…
Continue exploring
Other Healthcare stocks held by institutions
417 holders · $300.5B
416 holders · $881.6B
401 holders · $151.5B
398 holders · $415.6B
395 holders · $98.9B
394 holders · $111.8B
391 holders · $230.3B
386 holders · $303.9B
386 holders · $52.4B
383 holders · $114.2B
Data sourced from four public-disclosure sources: SEC 13F, Form 4, 13D/13G, and House/Senate STOCK Act disclosures. Not financial advice. Full disclaimer